Beam Therapeutics Inc at JPMorgan Healthcare Conference Transcript
All right. So I'm Eric Joseph, senior biotech analyst with JPMorgan. Our next presenting company is Beam Therapeutics. And presenting on behalf of the company is Chief Scientific Officer, Pino Ciaramella. We'll be doing Q&A in the room after the presentation. There should be mic runners around for those who want to ask a question from the floor. And if you don't, you can also submit a question via the digital conference book, and I'll work them in where appropriate.
So with that, Pino. Thank you.
Thank you very much, Eric. And thank you very much for giving me the opportunity to give you an update on behalf of Beam Therapeutics, a precision genetic medicine company that utilizes next-generation gene-editing technology known as base editing. Usual cautionary notes.
So our vision is really to provide life-long cures for patients suffering from serious diseases. With
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
